Josep M. Piulats
Institut Català d'Ornitologia(ES)Institut d'Investigació Biomédica de Bellvitge(ES)Institut Català d'Oncologia(ES)Duran i Reynals Hospital(ES)Centro de Investigación Biomédica en Red de Cáncer(ES)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Cancer Immunotherapy and Biomarkers, PARP inhibition in cancer therapy, Immunotherapy and Immune Responses, Ocular Oncology and Treatments
Most-Cited Works
- → Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy(2012)2,764 cited
- → Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma(2021)828 cited
- → Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer(2016)747 cited
- → Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study(2019)688 cited
- → Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring aBRCA1orBRCA2Gene Alteration(2020)664 cited
- → A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations(2018)419 cited